LATEST NEWS

Saliva-based COVID-19 screen proves fast, cheap and reliable
La Jolla, CA—Erica Ollmann Saphire, Ph.D., has been appointed President and CEO of La Jolla Institute for Immunology (LJI), the Institute announced today.
Testing for breast and ovarian cancers has come a long way—but at-risk patients still fall through the cracks. LJI scientist Anup Kumar Singh has won funding to learn more about cancer-causing mutations.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
"Clinical staff and non-medical volunteers are happy to be helping out"
LJI releases new COVID-19 vaccine guide
Myers Lab to expand autoimmune disease research, cancer and more
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia
"To prevent and treat the disease, it is vital to understand how the immune cells attack the body's own insulin-producing beta cells"
San Diego high school student Jeffrey Wang spearheads LJI research project, receiving national recognition as Regeneron Science Talent Search finalist
5 takeaways from February's "Live from the Lab" webinar